These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17060)

  • 41. Beta-adrenergic regulation of circadian rhythmicity of the renin-angiotensin-aldosterone system in five subtypes of essential hypertension.
    Cugini P; Manconi R; Mancini A; Serdoz R; Meucci T; Scavo D
    G Ital Cardiol; 1980; 10(2):184-90. PubMed ID: 6102942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of beta-adrenoceptor blocking agents on haemodynamic parameters.
    Hansson L
    Acta Med Scand Suppl; 1977; 606():49-54. PubMed ID: 19930
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of beta-adrenergic block on regional circulation].
    Sanguinetti M; Branzi A; Maresta A; Magnani B
    Boll Soc Ital Cardiol; 1970; 15(6):642-8. PubMed ID: 4397128
    [No Abstract]   [Full Text] [Related]  

  • 45. [Beta adrenergic receptor blockade in the treatment of arterial hypertension].
    Sznajderman M
    Kardiol Pol; 1976; 19(3):173-9. PubMed ID: 9530
    [No Abstract]   [Full Text] [Related]  

  • 46. [Hemodynamic effect of beta receptor blockaders in arterial hypertension].
    Anlauf M; Bock KD
    Verh Dtsch Ges Inn Med; 1974; 80():189-99. PubMed ID: 4156112
    [No Abstract]   [Full Text] [Related]  

  • 47. Changes in glomerular filtration rate during long term treatment with propranolol and peripheral vasodilators in patients with arterial hypertension.
    Ibsen H; Rasmussen K; Jensen HA; Leth A
    Dan Med Bull; 1979 Oct; 26(6):308-11. PubMed ID: 42515
    [No Abstract]   [Full Text] [Related]  

  • 48. [Relationship between renin-aldosterone system and efficacy of a beta-blocking agent in hypertensive patients].
    Armanini D; Guido R; Fallo F; Opocher G; Mantero F
    Clin Ter; 1976 Oct; 79(1):41-62. PubMed ID: 1017163
    [No Abstract]   [Full Text] [Related]  

  • 49. [Blocking of the renin-angiotensin-aldosterone system in the study and treatment of arterial hypertension].
    Villarreal H
    Arch Inst Cardiol Mex; 1983; 53(1):1-3. PubMed ID: 6135394
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of anaprilin on cardiac hemodynamic indices in elderly hypertensive patients].
    Severova NL
    Vrach Delo; 1983 May; (5):26-30. PubMed ID: 6136127
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hemodynamic and hormonologic basis of the treatment of arterial hypertension].
    Guédon J; Lucsko M; Chaignon M
    Arch Mal Coeur Vaiss; 1974 Oct; 67(10):1145-55. PubMed ID: 4156640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mode of action of beta-adrenergic blocking drugs in hypertension.
    Prichard BN; Owens CW
    Clin Physiol Biochem; 1990; 8 Suppl 2():1-10. PubMed ID: 1982756
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Therapy of hypertension. I. new antihypertensive agents, pharmacologic and pharmacokinetic bases. Beta-adrenergic blockers and blood pressure lowering].
    Brunner H
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():75-86. PubMed ID: 26152
    [No Abstract]   [Full Text] [Related]  

  • 54. Editorial: When to measure renin.
    Lancet; 1975 Apr; 1(7910):783-4. PubMed ID: 48006
    [No Abstract]   [Full Text] [Related]  

  • 55. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 56. Beta blockers in hypertension.
    Zacharias FJ
    Brux Med; 1973 Nov; Spec No(0):111-46. PubMed ID: 4154127
    [No Abstract]   [Full Text] [Related]  

  • 57. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of obsidan on cardiohemodynamic indicators in hypertension].
    Nazarenko VR
    Vrach Delo; 1976 Sep; (9):50-3. PubMed ID: 10676
    [No Abstract]   [Full Text] [Related]  

  • 59. [Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol].
    Stoschitzky K; Lindner W
    Wien Med Wochenschr; 1990 Apr; 140(6-7):156-62. PubMed ID: 1971978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical pharmacology of beta-adrenoceptor blocking drugs and therapeutic use in hypertension (author's transl)].
    Ebihara A
    Nihon Naika Gakkai Zasshi; 1980 Mar; 69(3):297-312. PubMed ID: 6103912
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.